Lurkin, I.

mutation tumor cancer patient bladder recurrence bladder cancer fgfr 3 mutations urine fgfr 3 mutation fgfr 3 detection analysis grade study wild-type assay tumours stage tumour stomach kinase pik 3ca mutations fgfr 3 status sample stromal tumors status group pdgfra receptor bladder tumors pik 3ca pathway microsatellite factor growth intestine follow-up alteration urothelial cell carcinoma carcinoma number frequency stromal urine samples marker cytology pik 3ca mutation cystoscopy van der kwast figure ras mutations sensitivity nmi-bc table fgfr 3 gene surveillance erasmus mc microsatellite alterations mutation status snapshot mutation assays pathology pathol multiplex result urothelial braf mutations fibroblast germany zwarthoff progression diagnosis addition signi ficantly therapy josephine nefkens institute tissue codon method